Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride treatment changes urine metabolomics and steroid signatures, potentially monitoring effectiveness but may cause sexual side effects.

Androgens are important for female fertility and could help in IVF treatment, but also play a role in causing PCOS.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Using rodents for research shows that health problems in the womb can cause diseases later in life.

Hormones and genetics affect hair growth and patterns, with some changes reversible and others not.

Methylated flavonoids may effectively reduce depression and inflammation caused by finasteride.

Lower SHBG levels may increase the risk of PCOS.

New tools show that in fish, NPY increases feeding and somatostatin decreases it.

The conclusion is that understanding the complex relationship between allergies, autoimmunity, and psychological factors is key to treating skin disorders with itching.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Stress hormone corticosterone blocks a growth factor to slow down hair stem cell activity and hair growth.

Most dogs with alopecia had higher than normal levels of certain hormones, but hair loss might not always be linked to these hormone changes.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Plant extracts can help prevent hair loss and promote hair growth.

High levels of testosterone and anti-Müllerian hormone before pregnancy are linked to a higher risk of newborns needing intensive care.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Maternal Nano-Se supplements improve fetal hair follicle development in cashmere goats.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

Many women experience sexual dysfunction, but few seek help, and better treatment and medical training are needed.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Uterine transplants for transgender women are feasible but need more research.

A new tool can analyze hair to detect changes due to hormones, genetics, and aging.

Melatonin and mitotane treatment led to hair re-growth in 62% of dogs with Alopecia X, but this was not always linked to normal hormone levels.